135 results
Page 3 of 7
8-K
tbgx4 t7ywc
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-1.1
tgavar9 mxboigehzwj
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-99.1
p3bvel1pxk2krscurj
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-99.2
3ntlc02gqmdk79qvv
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-5.1
5wfkvdmuq2s5rd
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
424B5
x39mv0kk
12 Feb 21
Prospectus supplement for primary offering
4:43pm
424B5
qvv8p7zw
10 Feb 21
Prospectus supplement for primary offering
4:40pm
8-K
EX-2.1
7zrk c7amdkhpfmwqsp
18 Nov 20
Completion of Acquisition or Disposition of Assets
5:18pm
S-8
EX-5.1
9lt6byrjya 0purd
30 Jul 20
Registration of securities for employees
9:50pm
8-K
EX-5.1
soooy0329 bskmld7x
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-99.1
s6pw0
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-99.2
4tkv8
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
sznt01ikmeonwlz
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-1.1
p7h s7mbv
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
424B5
rog5bypj1x1y exorj0
9 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
znbo ub3va28n
8 Jun 20
Prospectus supplement for primary offering
4:13pm